A community consultation period is open until 11 June 2014 for the drugs Simeprevir and Sofosbuvir. This provides an opportunity for anyone to make their voice heard about these drugs being considered for government subsidy through the Pharmaceutical Benefits Scheme (PBS).
You may provide comments using the PBAC online submission form, or alternatively, written feedback can be sent to:
PBAC Secretariat
MDP 952, Department of Health & Ageing
GPO Box 9848
Canberra, ACT, 2601
Email: [email protected].
Fax: 02
6289 4175.
You can provide feedback on both medications in the one form. Simply list both
medications in the first box titled Medicine
to which this submission relates and PBAC will count your
submission as relevant to both.